Join us as we take a few moments to relax and enjoy the beauty of Oxfordshire, Berkshire, Dorset, Hampshire and the Isle of Wight through the stunning images you have sent us this week.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.